Skip Navigation
A A A En Español Newsroom Contact Us Search:
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014
As the FDA observes National Minority Health Month this April, we are highlighting the Enhance EQUITY Initiative to raise awareness on the importance of improving the health of racial and ethnic minority populations and reducing health disparities. This year’s theme, “Better Health Through Better Understanding,” supports OMHHE’s mission to promote and protect the health of diverse populations through research and communication of science that addresses health disparities.
When the COVID-19 pandemic hit, ensuring one’s physical health became the priority. As the toll of social distancing and prolonged stay-in-place orders have shown, the importance of addressing mental health and well-being is integral to our COVID-19 response for all, but particularly for people of color. Minority communities across the nation have experienced greater rates of COVID-19-related hospitalizations and deaths. As we think about health disparities and racial inequity, we must do better to address minority mental health as well.
Each year in the United States, hundreds of babies are born with sickle cell disease (SCD), joining the nearly 100,000 American who already live with this disease. As pediatricians, we understand the challenges parents and caregivers face when attempting to secure the best and most effective care for their children. Unfortunately, when children living with sickle cell disease become adolescents and young adults, it can become even more difficult to navigate management and treatment options as health complications including pain crises often grow more intense and frequent. The poor adherence to treatment guidelines, lack of innovation, gaps in the delivery system, and underlying discrimination also add additional hurdles that make it difficult for people living with this disease to live a normal, high quality life.